SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. Letter

Journal of Urology

We wrote a reply discussing the use of oral ketorolac. FDA labelling is for such use only as continuation therapy after parenteral administration. We argue that there is no reason for this. The author reply builds on our argument.